COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 773: Articles 7721-7730  | Next

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
Bartsch, Y. C., Chen, J. W., Kang, J., Burns, M. D., St.Denis, K. J., Sheehan, M. L., Davis, J. P., Balazs, A. B., Yonker, L. M., Alter, G.
10.1101/2022.05.18.22275283 — Posted: 2022-05-21
Bias-adjusted predictions of county-level vaccination coverage from the COVID-19 Trends and Impact Survey
Reitsma, M. B., Rose, S., Reinhart, A., Goldhaber-Fiebert, J. D., Salomon, J. A.
10.1101/2022.05.18.22275217 — Posted: 2022-05-21
Early experience with modified dose nirmatrelvir/ritonavir in dialysis patients with coronavirus disease-2019
Brown, P. A., McGuinty, M., Argyropoulos, C. P., Clark, E. G., Colantonio, D., Giguere, P., Hiremath, S.
10.1101/2022.05.18.22275234 — Posted: 2022-05-21
Estimating Vaccine-Preventable COVID-19 Deaths Under Counterfactual Vaccination Scenarios in the United States
Zhong, M., Kshirsagar, M., Johnston, R., Dodhia, R., Glazer, T., Kim, A., Michael, D., Nair-Desai, S., Tsai, T. C., Friedhoff, S., Lavista Ferres, J. M.
10.1101/2022.05.19.22275310 — Posted: 2022-05-21
B cells, BAFF and interferons in MIS-C
Klocperk, A., Bloomfield, M., Parackova, Z., Aillot, L., Fremuth, J., Sasek, L., David, J., Fencl, F., Skotnicova, A., Rejlova, K., Magner, M., Hrusak, O., Sediva, A.
10.1101/2022.05.18.22275245 — Posted: 2022-05-21
Evaluation of the ID NOW Among Symptomatic Individuals During the Omicron Wave
Stokes, W., Venner, A., Buss, E., Tipples, G., Berenger, B. M.
10.1101/2022.05.19.22275316 — Posted: 2022-05-21
Building Medical Rehabilitation System with Safety and Without Interruption for the Patients with Coronavirus Disease 2019 Using the Functional Resonance Analysis Method (FRAM)
Sasanuma, N., Takahashi, K., Yanagida, A., Miyagi, Y., Yamakawa, S., Seo, T., Uchiyama, Y., Kodama, N., Domen, K.
10.1101/2022.05.18.22275242 — Posted: 2022-05-21
Targeting SARS-CoV-2 superspreading infections could dramatically improve the efficiency of epidemic control strategies in resource-limited contexts
Evans, M. V., Ramiadantsoa, T., Garchitorena, A., Kaffman, K., Moody, J., Nunn, C., Rabezara, J. Y., Raharimalala, P., Randriamoria, T. M., Soarimalala, V., Titcomb, G., Roche, B.
10.1101/2022.05.20.22275359 — Posted: 2022-05-21
Annual prevalence of non-communicable diseases and identification of vulnerable populations following the Fukushima disaster and COVID-19 pandemic
Murakami, M., Nomura, S.
10.1101/2022.05.18.22275293 — Posted: 2022-05-20
Parents' intention to vaccinate their child for COVID-19: a cross-sectional survey (CoVAccS - wave 3)
Smith, L. E., Sherman, S. M., Sim, J., Amlot, R., Cutts, M., Dasch, H., Sevdalis, N., Rubin, G. J.
10.1101/2022.05.20.22275350 — Posted: 2022-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).